SCHEMBL7984950

SCHEMBL7984950

Oc1ccc(-c2nc(O)c3c(ncn3Cc3ccccc3)n2)cc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.39
CSNK1D P48730 1/20 0.39
GAA P10253 3/20 0.39
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 2/20 0.38
MAPT P10636 2/20 0.38
GFER P55789 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PKM P14618 2/20 0.38
ALOX12 P18054 1/20 0.38
ADORA2A P29274 1/20 0.36
PARN O95453 1/20 0.36
CNOT7 Q9UIV1 1/20 0.36
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975267 0.87 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7988558 0.86 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7985336 0.86 PIK3CA (0.42) SMN1; SMN2ALDH1A1HPGDCSNK1DGAA
SCHEMBL7988787 0.85 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1HPGDCSNK1DGAA
SCHEMBL7975133 0.85 ADORA2A (0.50) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7984459 0.85 NR1H2 (0.43) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7974012 0.85 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7984659 0.85 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
Hydrochloric Acid SCHEMBL7985515 0.84 ADORA2A (0.49) SMN1; SMN2ALDH1A1HPGDGAAKMT2A
SCHEMBL7985325 0.84 HPGD (0.42) SMN1; SMN2ALDH1A1HPGDGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed